Improved menstrual hygiene management (MHM) is key to socioeconomic empowerment of women through improved well-being. Safe MHM is challenging in developing countries especially in rural and low-income settings. The study assessed the influence of World Vision’s piloted project of Nurturing Care Group approach on MHM in rural communities of Ghana. Four (4) communities each from Savelugu Municipal and Sekyere East District Assemblies were selected for a cross-sectional qualitative survey using 16 focus group discussions. Data was analysed using inductive mixed method with content analysis. Findings from 162 study participants showed satisfactory MHM awareness and practices among young and old females; MHM awareness and education sources included relatives, friends, NGOs, public and social institutions (e.g., health centres, churches, schools etc); intervention improved MHM understanding, behaviour and personal hygiene practices. Some MHM challenges that persisted included non-availability and prohibitive high cost of MHM materials, burden of managing menstrual pains, inadequate knowledge in handling menstrual intricacies, menstrual taboos, and stigma. Menstrual stigma was comparatively low among intervention communities than controls, but there was no difference regarding menstrual taboos across all communities largely due to religious and superstitious beliefs. Championing local production and use of reusable menstrual pads from fabrics was considered an innovation to ease sanitary pad cost burden and non-availability of menstrual pads. MHM was positively influenced through improved understanding of personal hygiene practices, and reduced stigmatization among others. Subsequent interventions would require adequate scope and resources to work with stakeholders to facilitate change processes with persistent MHM challenge like taboos.

The authors have declared no competing interest.

Funding was provided by World Vision US with contract ID SOW/PO Number 33514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical clearance certificate was secured from the Committee on Human Research and Publications Ethics (CHRPE) of the Kwame Nkrumah University of Science Technology was sought with reference number Ref: CHRPE/AP/418/21

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All the relevant data supporting the findings have been shared directly in the paper. However, the raw data set could be shared under reasonable request.